Roanoke Clinical Research

Roanoke Clinical Research is a dedicated clinical research site based in Roanoke, Virginia, specializing in the execution of Phase 1 through Phase 4 clinical trials. The company provides comprehensive site management services to pharmaceutical, biotechnology, and medical device sponsors, focusing on therapeutic areas such as endocrinology, pulmonology, and infectious diseases. In 2022, Roanoke Clinical Research was acquired by Aventiv Research, a move that integrated the site into a larger network of clinical trial centers. The facility is recognized for its experienced medical staff, including board-certified principal investigators, and its ability to recruit diverse patient populations for complex protocols. By maintaining high standards of data integrity and patient safety, the center plays a vital role in the clinical development of new therapies and vaccines.